The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The three scores are based on the trading styles of Growth, Value, and Momentum.

Growth Score A
Value Score A
Momentum Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Sanofi-aventis: (SNY)

(Real Time Quote from BATS)

 Add to portfolio

 ZacksTrade Now

$50.17 USD

+0.20 (0.40%)

Updated Mar 30, 2015 01:45 PM ET

Volume: 394,895

Open: $50.20

Prior Close: $49.97

Zacks Rank : 4-Sell [?]       4  

Style Scores [?] : Growth: C | Value: B | Momentum: D

The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style.

We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating:

Zacks Style Score A
Growth Score A
Value Score A
Momentum Score A
Income Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a score of an A or a B.

Zacks Scorecard Education - Learn more about the Zacks Scorecard

Brokerage Reports

Search for reports:

0 items in cart

SANOFI-AVENTIS [SNY]

Reports for Purchase

Showing records 1 - 20 ( 33 total )

Company: SANOFI-AVENTIS

Industry: LARGE CAP PHARMA

Record: 1

03/26/2015

Company Report

Pages: 9

Price: 24.95

Research Provided by a Third Party

Company: SANOFI-AVENTIS

Industry: LARGE CAP PHARMA

Record: 2

02/09/2015

Company Report

Pages: 9

Price: 24.95

Research Provided by a Third Party

Company: SANOFI-AVENTIS

Industry: LARGE CAP PHARMA

Record: 3

12/01/2014

Company Report

Pages: 11

Price: 24.95

Research Provided by a Third Party

Company: SANOFI-AVENTIS

Industry: LARGE CAP PHARMA

Record: 4

10/21/2014

Company Report

Pages: 12

Price: 24.95

Research Provided by a Third Party

Company: SANOFI-AVENTIS

Industry: LARGE CAP PHARMA

Record: 5

08/04/2014

Company Report

Pages: 9

Price: 24.95

Research Provided by a Third Party

Company: SANOFI-AVENTIS

Industry: LARGE CAP PHARMA

Record: 6

06/20/2014

Company Report

Pages: 11

Price: 24.95

Research Provided by a Third Party

Company: SANOFI-AVENTIS

Industry: LARGE CAP PHARMA

Record: 7

05/01/2014

Company Report

Pages: 9

Price: 24.95

Research Provided by a Third Party

Company: SANOFI-AVENTIS

Industry: LARGE CAP PHARMA

Record: 8

03/11/2014

Company Report

Pages: 10

Price: 24.95

Research Provided by a Third Party

Company: SANOFI-AVENTIS

Industry: LARGE CAP PHARMA

Record: 9

11/25/2013

Company Report

Pages: 11

Price: 24.95

Research Provided by a Third Party

Company: SANOFI-AVENTIS

Industry: LARGE CAP PHARMA

Record: 10

09/13/2013

Company Report

Pages: 10

Price: 24.95

Research Provided by a Third Party

Company: SANOFI-AVENTIS

Industry: LARGE CAP PHARMA

Record: 11

08/06/2013

Company Report

Pages: 10

Price: 24.95

Research Provided by a Third Party

Company: SANOFI-AVENTIS

Industry: LARGE CAP PHARMA

Record: 12

06/24/2013

Company Report

Pages: 13

Price: 24.95

Research Provided by a Third Party

Company: SANOFI-AVENTIS

Industry: LARGE CAP PHARMA

Record: 13

05/06/2013

Company Report

Pages: 9

Price: 24.95

Research Provided by a Third Party

Company: SANOFI-AVENTIS

Industry: LARGE CAP PHARMA

Record: 14

03/22/2013

Company Report

Pages: 11

Price: 24.95

Research Provided by a Third Party

Company: SANOFI-AVENTIS

Industry: LARGE CAP PHARMA

Record: 15

12/28/2012

Company Report

Pages: 11

Price: 24.95

Research Provided by a Third Party

Company: SANOFI-AVENTIS

Industry: LARGE CAP PHARMA

Record: 16

09/28/2012

Company Report

Pages: 11

Price: 24.95

Research Provided by a Third Party

Company: SANOFI-AVENTIS

Industry: LARGE CAP PHARMA

Record: 17

07/30/2012

Company Report

Pages: 9

Price: 24.95

Research Provided by a Third Party

Company: SANOFI-AVENTIS

Industry: LARGE CAP PHARMA

Record: 18

06/12/2012

Company Report

Pages: 10

Price: 24.95

Research Provided by a Third Party

Company: SANOFI-AVENTIS

Industry: LARGE CAP PHARMA

Record: 19

05/17/2012

Industry Report

Pages: 21

2012 ASCO PLANNER

Provider: RODMAN & RENSHAW, CO.

Analyst: KING M

Price: 75.00

Company: SANOFI-AVENTIS

Industry: LARGE CAP PHARMA

Record: 20

05/01/2012

Company Report

Pages: 10

Price: 24.95

Research Provided by a Third Party